{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Kodiak Sciences Inc"},"Symbol":{"label":"Symbol","value":"KOD"},"Address":{"label":"Address","value":"1200 PAGE MILL ROAD, PALO ALTO, California, 94304, United States"},"Phone":{"label":"Phone","value":"+1 650 281-0850"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.kodiak.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Pablo Velazquez-Martin","title":"SVP-Clinical Research & Translational Medicine"},{"name":"Victor Perlroth","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}